gradenko_2000 posted:

https://twitter.com/BNONews/status/1698437917687902657?t=0e_o5RHSMrQYmj4QZc18zA&s=19

nexous posted:

as another alcoholic that sucks to hear

Parity warning posted:

Asproigerosis posted:

I find it very funny seeing someone out in the wild wearing a surgical mask but dicknosing, it's such a wild whirlwind of decisions.

Also my anecdotal experience with scanning liver failure/mets so bad your liver is now just an apartment for cancer is that is one of the worst ways to slowly die.

https://www.ctinsider.com/connecticut/article/covid-omicron-cancer-deaths-study-18338073.php posted:

The Centers for Disease Control and Prevention and its Healthcare Infection Control Practices Advisory Committee are coming under fire for considering relaxing infection control guidelines at hospitals and other medical settings, even as cases of the Eris variant of COVID are on the rise.

A recent study published last week in the Journal of the American Medical Association highlights the need for strict infection controls in health care facilities.

“During the Omicron wave, which was characterized by high transmission of COVID-19, we saw high COVID-19 mortality among patients with cancer,” wrote study author Alexandra Potter, clinical research coordinator at Massachusetts General Hospital. “It’s possible that in this upcoming wave … that we may see another spike in COVID-19 mortality among patients with cancer.”
(..)
“The pandemic is ‘over’ according to some, but clearly, it’s not over for others,” said Dr. Roberts. He said he was worried about cancer patients because vaccines do not work as well for them. Some cancer treatments also cause immunosuppression. “If you think about that patient and all of a sudden there are no masks, no testing … what tools do we have left to help them?”
(..)
An open letter to the CDC called on the agency to reverse course on loosening infection prevention measures. The letter was signed by scientists, epidemiologists, healthcare workers and researchers, including two professors from Yale.

“We have called on the CDC to fully recognize aerosol transmission," said Rocelyn De Leon-Minch, an industrial hygienist for National Nurses United which is at the forefront of the push for the CDC to strengthen infection controls. She said that it was particularly important that the CDC not equivocate on surgical masks with N95 respirators for airborne infection control.

“Four years into the pandemic and we know these measures work,” said De Leon-Minch. “Unfortunately (the committee) is still refusing to recognize the science on aerosol transmission. It’s really ridiculous.”
(..)
The study authors say that their findings highlight the need for reconsidering infection controls, such as masking in hospitals for patients who have cancer and other immune-compromising diseases.
(..)
“This study points toward the fact that vulnerable groups continue to be impacted quite severely by COVID-19,” Roberts said. “We need to think carefully about removing COVID restrictions.”

https://jamanetwork.com/journals/jamaoncology/fullarticle/2809037?guestAccessKey=85118918-ccbf-4525-bfd9-90914fdc12ad posted:

Key Points
Question Did COVID-19 mortality differ between patients with cancer and the general US population depending on which SARS-CoV-2 variant was dominant?

Findings Among 34 350 patients with cancer who died during the COVID-19 pandemic during periods in which wild-type, Delta, and Omicron variants were predominant between March 2020 and May 2022, the number of deaths was higher during the winter Omicron surge compared with the preceding year’s winter surge of the wild-type variant. In contrast, there were 29% fewer COVID-19 deaths in the general population during the winter Omicron surge compared with the preceding year’s winter surge.

Meaning Findings of this study suggest that patients with cancer experienced a disparate burden of COVID-19 mortality during the winter Omicron wave; strategies to prevent COVID-19 transmission should remain a high priority as new variants arise.

Abstract
Importance With the ongoing relaxation of guidelines to prevent COVID-19 transmission, particularly in hospital settings, medically vulnerable groups, such as patients with cancer, may experience a disparate burden of COVID-19 mortality compared with the general population.

Objective To evaluate COVID-19 mortality among US patients with cancer compared with the general US population during different waves of the pandemic.

Design, Setting, and Participants This cross-sectional study used data from the Center for Disease Control and Prevention’s Wide-Ranging Online Data for Epidemiologic Research database to examine COVID-19 mortality among US patients with cancer and the general population from March 1, 2020, to May 31, 2022. The number of deaths due to COVID-19 during the 2021 to 2022 winter Omicron surge was compared with deaths during the preceding year’s COVID-19 winter surge (when the wild-type SARS-CoV-2 variant was predominant) using mortality ratios. Data were analyzed from July 21 through August 31, 2022.

Exposures Pandemic wave during which the wild-type variant (December 2020 to February 2021), Delta variant (July 2021 to November 2021), or Omicron variant (December 2021 to February 2022) was predominant.

Main Outcomes and Measures Number of COVID-19 deaths per month.

Results The sample included 34 350 patients with cancer (14 498 females [42.2%] and 19 852 males [57.8%]) and 628 156 members of the general public (276 878 females [44.1%] and 351 278 males [55.9%]) who died from COVID-19 when the wild-type (December 2020-February 2021), Delta (July 2021-November 2021), and winter Omicron (December 2021-February 2022) variants were predominant. Among patients with cancer, the greatest number of COVID-19 deaths per month occurred during the winter Omicron period (n = 5958): at the peak of the winter Omicron period, there were 18% more deaths compared with the peak of the wild-type period. In contrast, among the general public, the greatest number of COVID-19 deaths per month occurred during the wild-type period (n = 105 327), and at the peak of the winter Omicron period, there were 21% fewer COVID-19 deaths compared with the peak of the wild-type period. In subgroup analyses by cancer site, COVID-19 mortality increased the most, by 38%, among patients with lymphoma during the winter Omicron period vs the wild-type period.

Conclusions and Relevance Findings of this cross-sectional study suggest that patients with cancer had a disparate burden of COVID-19 mortality during the winter Omicron wave compared with the general US population. With the emergence of new, immune-evasive SARS-CoV-2 variants, many of which are anticipated to be resistant to monoclonal antibody treatments, strategies to prevent COVID-19 transmission should remain a high priority.

Asproigerosis posted:

I find it very funny seeing someone out in the wild wearing a surgical mask but dicknosing, it's such a wild whirlwind of decisions.

Also my anecdotal experience with scanning liver failure/mets so bad your liver is now just an apartment for cancer is that is one of the worst ways to slowly die.

RandomBlue posted:

Was in Memphis recently and saw someone at Home Depot double masked, cloth over surgical, and dick nosing. WTF are you even doing?

nexous posted:

it’s cool I was born infertile so I don’t have to get Covid to save the earth

Turtle Sandbox posted:

drat, I paid for mine. I assume it's better through surgery than disease, though.

Asproigerosis posted:

I find it very funny seeing someone out in the wild wearing a surgical mask but dicknosing, it's such a wild whirlwind of decisions..

Animal-Mother posted:

I suppose mortality was always like that, though.

tangy yet delightful posted:

the hits keep coming, and they don't stop coming


sorry your dad got got, hope he has an easy time of it

BOGO LOAD posted:

last night a DJ saved my life

maxwellhill posted:

noooooooo they do not lol

BCR posted:

Question: Moderna ba 4-5, Pfizer ba 4-5, or original novavax for booster no 5.

I'm leaning to novavax again for wider, general protection again or Moderna for Pokémon completion vibes.

Any data on effectiveness to hand?

BCR posted:

Question: Moderna ba 4-5, Pfizer ba 4-5, or original novavax for booster no 5.

I'm leaning to novavax again for wider, general protection again or Moderna for Pokémon completion vibes.

Any data on effectiveness to hand?

gradenko_2000 posted:

https://twitter.com/BNONews/status/1698437917687902657?t=0e_o5RHSMrQYmj4QZc18zA&s=19

Tzen posted:

posting on the pestilence page
https://twitter.com/wsbgnl/status/1698494078256566404

BCR posted:

No xbb vaccines for at least another 6 months to a year I think.

This is Australia being conservative and gate keeping.

Steve Yun posted:

could be anything! including Covid induced liver failure in somebody who already has alcohol induced cirrhosis

https://www.mdpi.com/2077-0383/11/14/4249/htm


https://twitter.com/shawng927/status/1293691226609332224?s=46

Pillowpants posted:

bahahaha Sturgis